Interaction of SNX482 with domains III and IV inhibits activation gating of alpha(1E) (Ca(V)2.3) calcium channels.
We have investigated the action of SNX482, a toxin isolated from the venom of the tarantula Hysterocrates gigas, on voltage-dependent calcium channels expressed in tsa-201 cells. Upon application of 200 nM SNX482, R-type alpha(1E) calcium channels underwent rapid and complete inhibition, which was only poorly reversible upon washout. However, upon application of strong membrane depolarizations, rapid and complete recovery from inhibition was obtained. Tail current analysis revealed that SNX482 mediated an approximately 70 mV depolarizing shift in half-activation potential, suggesting that the toxin inhibits alpha(1E) calcium channels by preventing their activation. Experiments involving chimeric channels combining structural features of alpha(1E) and alpha(1C) subunits indicated that the presence of the domain III and IV of alpha(1E) is a prerequisite for a strong gating inhibition. In contrast, L-type alpha(1C) channels underwent incomplete inhibition at saturating concentrations of SNX482 that was paralleled by a small shift in half-activation potential and which could be rapidly reversed, suggesting a less pronounced effect of the toxin on L-type calcium channel gating. We conclude that SNX482 does not exhibit unequivocal specificity for R-type channels, but highly effectively antagonizes their activation.
Bourinet
E
E
Physiopathologie des Canaux Ioniques, Institut de Génétique Humaine, CNRS UPR1142, 34396 Montpellier Cedex 5, France. emmanuel.bourinet@igh.cnrs.fr
Stotz
S C
SC
Spaetgens
R L
RL
Dayanithi
G
G
Lemos
J
J
Nargeot
J
J
Zamponi
G W
GW
D000818:Animals; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000494:pharmacology*; D015220:Calcium Channels / Q000737:chemistry* / Q000378:metabolism*; D020746:Calcium Channels, L-Type / Q000737:chemistry / Q000378:metabolism; D020908:Calcium Channels, R-Type / Q000378:metabolism; D027682:Cation Transport Proteins; D004594:Electrophysiology; D015640:Ion Channel Gating / Q000187:drug effects*; D010456:Peptides, Cyclic / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D051381:Rats; D013111:Spider Venoms / Q000378:metabolism* / Q000494:pharmacology*; D013112:Spiders
C498917:Cacna1e protein, rat; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D020908:Calcium Channels, R-Type; D027682:Cation Transport Proteins; D010456:Peptides, Cyclic; C115521:SNX 482; D013111:Spider Venoms; C082807:omega-grammotoxin SIA